Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Neuropsychiatric Disease and Treatment|March 12, 2016
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaDiego Novick, William Montgomery, Josep Maria Haro, et al.Headache|September 29, 2025
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH studyRichard B Lipton, Miguel J A Láinez, Zubair Ahmed, et al.Journal of Psychiatric Research|May 12, 2012
Regional differences in treatment response and three year course of schizophrenia across the worldDiego Novick, Josep Maria Haro, Jihyung Hong, et al.The Journal of Nervous and Mental Disease|September 16, 2009
Validity and reliability of the Hamilton depression rating scale (5 items) for manic and mixed bipolar disordersAna González-Pinto, Fernando Mosquera, Catherine Reed, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 19, 2005
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) studyDiego Novick, Manuel Bousono, David Suarez, et al.Frontiers in Neurology|February 5, 2026
The diagnostic pathway of Alzheimer's disease in real-world clinical practice in Spain: results from the Adelphi Dementia Disease Specific Programme™Pascual Sánchez-Juan, Pablo Baz, Enrique Arrieta, et al.Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|August 24, 2016
Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthoodTamás Treuer, Kwok Ling Phyllis Chan, Bung Nyun Kim, et al.Neuropsychiatric Disease and Treatment|October 13, 2018
Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertralineJia Huang, Yun Wang, Jun Chen, et al.Journal of Medical Economics|July 28, 2015
Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic reviewGebra Cuyun Carter, Denise T King, Lisa M Hess, et al.Journal of Medical Economics|May 9, 2019
Retrospective analysis of patients with advanced or metastatic gastric cancer in ColombiaDiego Novick, Felice Leonardi, Daniel Lee Kay Pen, et al.Pageof 10